Strategic Partnership Announcement
APR Pharma, Vetio and Eytelia announce partnership for the use of Kynosil in Animal Health products.
We are proud to announce a strategic partnership between APR Pharma, Eytelia and Vetio to bring Kynosil, a patented and highly bioavailable Silicium ingredient, to the world of pet supplements.
Kynosil addresses a key challenge in animal nutrition—silica’s poor bioavailability in typical diets. Combined with Vetio’s patented softchew technology, this innovation delivers a stable, palatable, and effective supplement that pets love.
Maarten De Gussem, Director of APR Pharma, adds:
“Through this partnership, Vetio, APR Pharma, and Eytelia will bring years of combined scientific expertise to formulate the very best skin care, mobility, and other wellness products for pets.”
As David Ryder, Vetio Animal Health’s UK and EU Director commented:
“We are excited to bring this innovative ingredient to our customers through formulated products that will improve the health and wellbeing of pets. There is significant supporting data in many species, and we will be engaging in further research to demonstrate the impact this technology will have on our beloved pets.”
KynoSil for Dogs
PegaSil for Horses
Our Blog
Latest news
Contact
Contact Us!
Our professional team help you with pleasure and answer to your questions.
Would you like to know more about the products?
Fill out the form below and our colleagues will contact you shortly.